A new study identified 3 trajectories, based on projected stability, for preclinical Alzheimer disease progression.
In this Healio video, Christopher Lock, MD, discusses highlights in anti-amyloid therapies for Alzheimer’s disease presented ...
Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...
The FDA recently cleared the Lumipulse blood test for early diagnosis of Alzheimer's disease in people 55 and over with memory loss. The noninvasive Lumipulse blood test measures the levels of two ...
New Delhi: Alzheimer’s is a brain disease that is characterised by a decline in memory, thinking, and reasoning skills. Alzheimer’s is not a normal part of aging, and it worsens over time. Alzheimer’s ...
A new study suggests a surprisingly simple compound could help fight Alzheimer’s disease. Researchers found that arginine—an inexpensive amino acid already considered safe—can reduce the buildup of ...
Menopause happens to every woman, and it may hold clues as to why women are at a greater risk for Alzheimer’s disease. Yale ...
Add Yahoo as a preferred source to see more of our stories on Google. Dr Dale Bredesen, a neurologist who has worked in many of California’s major universities, boldly claims that Alzheimer’s disease ...
Subtle biological changes linked to Alzheimer's disease may begin as early as the late 50s—decades before memory loss or ...
The FDA has approved Auvelity (dextromethorphan HBr/bupropion HCl) for Alzheimer disease agitation, providing a non-antipsychotic option based on ADVANCE-1 and ACCORD-2 data.
A new study finds that a simple blood test could predict Alzheimer's disease long before symptoms appear.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results